XML 63 R30.htm IDEA: XBRL DOCUMENT v3.20.1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2020
Share-based Payment Arrangement [Abstract]  
Summary of the Components of Total Stock-Based Compensation Expense The following table summarizes the components of total stock-based compensation expense included in the condensed consolidated statements of operations for the periods presented.
 
Three Months Ended
March 31,
 
2020
 
2019
 
(In thousands)
Cost of revenues
$
606

 
$
231

Research and development
1,919

 
716

Sales and marketing
1,942

 
999

General and administrative
3,048

 
1,288

Restructuring

 
55

Total
$
7,515

 
$
3,289


Summary of Stock-Based Compensation Associated with Each Type of Award
The following table summarizes the various types of stock-based compensation expense for the periods presented.
 
Three Months Ended
March 31,
 
2020
 
2019
 
(In thousands)
Stock options, RSUs, and PSUs
$
7,077

 
$
3,222

Employee stock purchase plan
438

 
67

Total
$
7,515

 
$
3,289


Summary of Stock Option Activity
The following is a summary of stock option activity.
 
Number of
Shares
Outstanding
 
Weighted-
Average
Exercise Price
per Share
 
Weighted-
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
(1)
 
(In thousands)
 
 
 
(Years)
 
(In thousands)
Outstanding at December 31, 2019
4,097

 
$
2.18

 
 
 
 
Granted

 

 
 
 
 
Exercised
(541
)
 
2.58

 
 
 
$
28,263

Canceled
(73
)
 
7.44

 
 
 
 
Outstanding at March 31, 2020
3,483

 
$
2.01

 
4.2
 
$
105,469

Vested and expected to vest at March 31, 2020
3,483

 
$
2.01

 
4.2
 
$
105,469

Exercisable at March 31, 2020
2,518

 
$
2.22

 
4.1
 
$
75,706

 
 
(1)
The intrinsic value of options exercised is based upon the value of the Company’s stock at exercise. The intrinsic value of options outstanding, vested and expected to vest, and exercisable as of March 31, 2020 is based on the closing price of the Company’s stock fair value on March 31, 2020 or the earlier of the last trading day prior to March 31, 2020, if March 31, 2020 is a non-trading day. The Company’s stock fair value used in this computation was $32.29 per share.
Summary of Stock Option Outstanding
The following table summarizes information about stock options outstanding at March 31, 2020.
 
 
Options Outstanding
 
Options Exercisable
Range of Exercise Prices
 
Number of
Shares
 
Weighted-
Average
Remaining
Life
 
Weighted-
Average
Exercise
Price
 
Number of
Shares
 
Weighted-
Average
Exercise
Price
 
 
(In thousands)
 
(Years)
 
 
 
(In thousands)
 
 
$0.70 —– $1.11
 
751

 
4.8
 
$
0.82

 
565

 
$
0.80

$1.29 —– $1.29
 
1,000

 
4.5
 
1.29

 
625

 
1.29

$1.31 —– $1.31
 
1,037

 
4.0
 
1.31

 
765

 
1.31

$1.37 —– $12.57
 
653

 
3.3
 
4.78

 
527

 
5.34

$14.58 —– $14.58
 
42

 
6.1
 
14.58

 
36

 
14.58

Total
 
3,483

 
4.2
 
$
2.01

 
2,518

 
$
2.22


Summary of Restricted Stock Unit Activity
The following is a summary of RSU activity.
 
Number of
Shares
Outstanding
 
Weighted-
Average
Fair Value
per Share at
Grant Date
 
Weighted-
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
(1)
 
(In thousands)
 
 
 
(Years)
 
(In thousands)
Outstanding at December 31, 2019
4,263

 
$
7.19

 
 
 
 
Granted
552

 
31.34

 
 
 
 
Vested
(951
)
 
6.13

 
 
 
$
34,095

Canceled
(34
)
 
16.92

 
 
 
 
Outstanding at March 31, 2020
3,830

 
$
10.85

 
1.3
 
$
123,672

Expected to vest at March 31, 2020
3,830

 
$
10.63

 
1.3
 
$
114,306

 
 
(1)
The intrinsic value of RSUs vested is based upon the value of the Company’s stock when vested. The intrinsic value of RSUs outstanding and expected to vest as of March 31, 2020 is based on the closing price of the Company’s stock on March 31, 2020 or the earlier of the last trading day prior to March 31, 2020, if March 31, 2020 is a non-trading day. The Company’s stock fair value used in this computation was $32.29 per share.
Share-based Compensation, Performance Shares Award Outstanding Activity
The following is a summary of PSU activity.
 
Number of
Shares
Outstanding
 
Weighted-
Average
Fair Value
per Share at
Grant Date
 
Weighted-
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
(1)
 
(In thousands)
 
 
 
(Years)
 
(In thousands)
Outstanding at December 31, 2019
955

 
$
9.83

 
 
 
 
Granted
482

 
11.52

 
 
 
 
Vested
(1,410
)
 
10.41

 
 
 
$
50,938

Canceled

 

 
 
 
 
Outstanding at March 31, 2020
27

 
$
4.40

 
0
 
$
872

 
 
(1)
The intrinsic value of PSUs vested is based upon the value of the Company’s stock when vested. The intrinsic value of PSUs outstanding and expected to vest as of March 31, 2020 is based on the closing price of the Company’s stock on March 31, 2020 or the earlier of the last trading day prior to March 31, 2020, if March 31, 2020 is a non-trading day. The Company’s stock fair value used in this computation was $32.29 per share.